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However, protein synthesis was found to continue at nearly 
normal levels after hail' plucking. 
The possible presence of an inhibitor of ODC activity was 
suggested by reports of a macromolecular ODC "antizyme" 
that can be recovered from liver after treatment with exogenous 
polyamines [7-9]. The recovery of substantially greater ODC 
activity in preparations of plucked skin after treatment with 
10% (NH4)2S04 was consistent with the reported behavior of 
liver antizyme [10). Extraction of plucked skin under the ap-
propriate conditions resulted in the recovery of an inhibitory 
substance that had a molecular weight apparently greater than 
30,000. Rat liver antizyme has a reported molecular weight of 
26,500 [10] and chicken liver antizyme has a molecular weight 
of 19,500 [9). The recovery of increased amounts of inhibitor 
after treatment of plucked skin extracts with 10% (NH4hS04 is 
consistent with an antizyme-like inhibitor. The activation and/ 
or release of this inhibitor by physiologic means, hair plucking, 
raises the possibility that modulation of this molecule may be 
involved in the cyclical regulation of hair growth and/or the 
ordered differentiation of the epidermis. 
We thank Ms. Judith Thorpe for her expert technical assist-
ance. 
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Previous studies in our laboratory using immunoelec-
tron microscopy have shown that anti-T6 monoclonal 
antibody reacts with all epidermal Langerhans cells in 
normal skin. Comparison of the number of T6-positive 
(+) epidermal cells with la (HLA-DR) (+) cells, as defined 
by the monoclonal antibodies, anti-Il and anti-12, dis-
closed that these latter markers significantly underesti-
mated Langerhans cell and indeterminate cell numbers 
(p < 0.01 and p < 0.001, respectively) when employed in 
a sensitive 4-step immunoperoxidase procedure. Thus, it 
appears that' all epidermal Langerhans cells and indeter-
mina te cells are not la-positive as defined in this system 
and that Ia(+)/T6(+) and la(-)/T6(+) subsets exist. 
These subsets may be analogous to the la( +) and la( -) 
subsets of macro phages, in which the former are respon-
sible for antigen interaction with T cells. 
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Abbreviations: 
PAP: peroxidase-antiperoxidase 
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These findings indicate T6 reactivity is more sensitive 
than la reactivity in defining the Langerhans cell and 
indeterminate cell populations in normal skin. Further-
more, other la-positive cells frequently infiltrate the ep-
idermis in inflammatory cutaneous disorders. It is pro-
posed that T6 reactivity is more specific than Ia reactiv-
ity and will better reflect the numbers of epidermal 
Langerhans cells and indeterminate cells in such reac-
tions. 
In 1975, Hammerling and his colleagues showed that cells 
expressing la antigens were present within murine ep idermis 
[1]. Several investigators have concluded that LangeI'hans cells 
and indeterminate cells (thought to be Langerhans cell precur-
sors) are the only normal inhabitants of human epidermis to 
express la-like (HLA-DR) antigens on theil' surface [2-4]. 
Hence, in normal human epidermis, la-like antigens have been 
considered to be highly specific markers for Langerhans cells 
and their precursors. 
Recently, a monoclonal antibody, anti-T6, was developed 
that reacts with 70% of thymocytes but not with peripheral T 
cells [5,6). Using an immunoperoxidase electron microscopic 
technique, Murphy et al [7,8] have shown that anti-T6 antibody 
labels intraepidermal Langerhans cells. This observation was 
corroborated by la (anti-II) and T6 double-labeling studies 
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[9]. Indeterminate cells within the epidermis and dermis are 
also T6-positive [10]. Thus, in normal hllman epidermis, T6 
antigen also appears to be a highly specific marker for Langer-
hans cells and t heir precursors. Moreover , T6(+) cells, which 
resemble Langerhans cells, have been identified in lymph nodes 
[5]. These cells most likely represent Langerhans cells that 
have migrated to lymph nodes [11]. 
OUT work, using control normal human skin for comparison 
with diseased skin in several disease entities, has led us to doubt 
th e sensitivity of la reactivity relative to T6 reactivity in iden-
tifying Langerhans cells. This study was therefore undertaken 
to determine whether T6 antigen is a more sensitive marker for 
Langerhans and indeterminate cells in normal human epider-
mis. The reactivity of two monoclonal anti-Ia (HLA-DR) anti-
bodies and monoclonal anti-T6-antibody was compared in tis-
sue sections. The results show that Ia antigens are detectable 
on only 18-63% of the numbers of T6-defined Langerhans cells 
and indeterminate cells in normal human epidermis when stud-
ied by a 4-step immunoperoxidase technique. 
MATERIALS AND METHODS 
Subjects 
Five healthy adults, 2 women and 3 men, aged 20-34 years, were 
selected. Each individual underwent 1 biopsy procedw-e of clinically 
normal skin. 
Shin Biopsies 
A single 3- or 4-mm punch biopsy specimen was taken from t he 
extensor forearm in 3 subjects a nd the posterior shou lder in 2 subjects. 
Xylocaine (1%) without epinephrine was injected around but not into 
the site of biopsy. Each t issue specimen was frozen in OCT compound 
(Ames Co., Division of Miles Laboratory, Inc., E lkhart, Indiana) and 
stored at -70°C. 
Monoclonal Antibodies 
Two monoclonal ant ibodies, a nt i-II and anti-I2, reactive with non-
polymorphic regions of human la-like (HLA-DR) ant igens were used. 
The specificity and characteristics of these antibodies have been pub-
lished previously [12,13]. In brief, anti-II antibody reacts with > 90% of 
B cells a nd macrophages and 20- 30% of null cells. While umeactive 
with nonactivated T cells, anti-II antibody reacts with 20-70% of 
activated T cells according to the stimulus used [12]. Anti-Il antibody 
specifically precipitated the two bands (Laz 388, 221) at 34,000 and 
29,000 daltons which defme the components of the Ia antigen. Ant i-I2 
antibody is reactive with the vast majority of B cells and monocytes, 
20% of null cells, 30-40% of activated T cells, a nd virtua lly no resting T 
cells [13]. Anti-I2 antibody also precipitates the two bands (Laz 221) 
that define la-antigen components [13]. Anti -Il antibody appears to 
precipi tate these two bands in gr eater quan t ity than anti-I2 antibody. 
The method of production and reactivity of monoclonal anti-T6 
antibody has been described previously [5-8,14]' T6 antigen on the 
surface of thymocytes has been partia lly characterized. It is a 49,000-
dalton glycoprotein and is associated with /l,-microglobulin [15]. The 
character of the antigen on Langerhans cells is unknown at present. 
Indirect Inununofluoresence Procedure 
Four micron-thick frozen sections taken - 10 i1m apru·t, from biopsy 
specimens of subjects 1. and 2, were processed as described in detail 
previously [16]. Initially, the sections were incubated with a 1:100 
dilution of either anti-Il or anti-T6 monoclonal a ntibodies at room 
temperature in a moist chamber. After washing with phosphate-
buffered saline (PBS) , the sections were incubated similarly for 30 min 
with a 1:20 dilution of tluoresceinated goat antimouse IgG (Cappel 
Laboratories, Cochranville, Pennsylvania). After washing in PBS, the 
sections were overla id with E lvanol (E.!. Dupont de Nemours and Co., 
Wilmington, Delawru'e), and examined using a Zeiss fl ourescence mi-
croscope with epi-illumination. 
Immunoperoxidase Procedure 
Four micron-thick frozen sections taken - 10 urn aprut, from biopsy 
specimens of a ll 5 subjects, were air -dried, fixed in acetone for 5 min, 
and stained by a 4-step peroxidase-ant i peroxidase (PAP) method de-
scribed in detail e lsewhere [5,14]' Sections were incubated with a 1:500 
dilution of mouse ascites fluid containing either anti-Il, anti-I2, or a nti-
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T6 monoclonal antibodies for 60 min at room temperature followed by 
30 min separate incubations with rabbit antimouse Ig (Dako Immuno-
globulins, Copenhagen, D enmark) , swine ant irabbi t Ig, a nd lastly, per-
oxidase-rabbit-antiperoxidase reagent (Dako). 
Staining was achieved by incubation of sections in an acetate buffer 
solu tion (pH 5.0) that contained 3-amino-9-ethylcarbazole (Aldrich 
Cllemical Co., Inc., Milwaukee, Wisconsin) , dimethylfonnamide, and 
hydrogen peroxide. The sections were then washed in acetate buffer, 
coun terstained with Gill's b'iple-strength hematoxylin, and m ounted in 
Elvanol (E.I. Dupont de Nemow-s & Co. ). 
Counting Method 
From each biopsy of a ll 5 subjects, 2 or 3 sections were each stained 
sepru'ately by the PAP technique with an t i-Il an tibody, anti-I2 an t i-
body, or anti-T6 antibody. Biopsies from subjects 1 and 2 were also 
processed by the indirect immunofluorescence technique. A total of 8 
mm of epidermal length from the sections of each individual biopsy 
specimen stained with ant i-Il , ant i-I2, or anti-T6 antibodies was meas-
ured on a Zeiss light or fluorescence microscope with an oculru' microm-
eter (Zeiss W KPL, lOX; accuracy < 10 JLm). The number of l a-positive 
(11- or I2-posit ive) and T 6-posit ive intraepidermal cells were counted. 
A cell was counted only if the nucleus, visible as negative staining, was 
present. Dendrites were not counted. The number of ceUs stained by 
each antibody was divided by the total epidermal length (mm) surveyed 
to obtain the number of either la-positive cells or T6-positive cells per 
lineru' mm in 4 JLm- thick frozen sections. 
Statistical M ethod 
The standru'd Student's t-test was employed. 
RESULTS 
Immunofluorescence and Immunoperoxidase Procedure 
Findings were similar using both indirect immunofluores-
cence and immunoperoxidase techniques. Within the epidermis, 
la-positive and T6-positive cells were identified in the frozen 
tissue sections as cells with diffuse apparent cytoplasmic stain-
ing (Fig 1). Both the cell bodies and delicate dendritic processes 
FIG 1. Normal human skin (subject 1) stained by a 4-step PAP 
procedure (400X , Gill's triple-strength hematoxylin coun terstain). A, 
Anti-1'6 monoclonal antibody reactivity. The dendrites and cell bodies 
of numerous Langerhans cells are stained in the epidermis. B, Anti-I2 
(HLA-DR) monoclonal antibody reactivity. The cell bodies of fewer 
Langerhans cells, as compru'ed to (A), ru'e stained. Endothelial cells and 
" fibrohistiocytes" exhibit positivi ty in the dermis. 
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were uniformly stained. Nuclei were visible as a central oval 
zone of nonreactivity (Fig 2). Due to the intensity and uniform-
ity of t he staining, delineation of the specific site (membrane 
vs. cytoplasm) of t he reaction was not possible. As noted in 
previous work (our unpublished data), the acrosyringium was 
la-positive as well. 
In the dermal mesenchymal tissue, anti-II a nd anti-12 anti-
bodies reacted with endothelial cells, and rare cells considered 
to be fibrohistiocytes. Anti-T6 antibody reacted with only a few 
dermal dendritic cells, probably indeterminate cells or dermal 
Langerhans cells . 
Numbers of la-positive and T6-positive lntraepidermal 
Dendritic Cells 
In all 5 subjects studied by the immunoperoxidase technique 
and in both subjects studied by indirect immunofluorescence, 
FIG 2. Normal human skin (sections taken no greater than 20 fLm 
apart) stained by a 4-step PAP procedure. (640x, Gill's triple-strength 
hematoxylin counter-stain) . A cell was counted as positive only if the 
cell body was stained and a negative impression of the nucleus was 
visible. The method of counting was identical for all specimens. A, 
Anti-T6 monoclonal antibody reactivity. Three positive cells are pres-
ent in this field (arrowheads ). B , Anti-ll (HLA-DR) monoclonal 
antibody reactivity. One positive cell is present in this field (arrow-
head). 
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the number of T6-positive cells was approximately 2- to 3-fold 
the number of la-positive cells (Table I), as demonstrated in 
Fig 1. Anti-II antibody uniformly identified more la-positive 
cells than anti-I2 antibody. The mean number of T6-reactive 
cells was significantly greater than that of II-reactive cells (p 
< 0.01) or 12-reactive cells (p < 0.001) . These observations h eld 
true in both relatively sun-exposed (extensor forearm) and non-
sun-exposed (posterior shoulder) skin. Indeed, the greatest 
number of anti-II-reactive cells per lineal' mm (Case 1,5.5 cells) 
was less than the smallest number of T6-positive cells (Case 5, 
6.0 cells) observed in any of the PAP-processed specimens. 
DISCUSSION 
The Birbeck granule has traditionally been accepted as the 
most definitive marker of the Langerhans cell [17). The only 
other cell consistently known to contain this structure is the 
histiocytosis-X cell, which is thought to represent an abnormal 
or neoplastic Langerhans cell [18). We recently have shown 
that histiocytosis-X cells are T6-positive [19] as previously 
predicted [7). Because transmission electron microscopy is re-
quired to identify Bir'beck granules, difficulty in evaluation of 
large numbers of Langerhans cells is encountered . Furthermore, 
when granules are sparse, tedious serial sectioning of cells is 
necessary to establish the identity of the cells. Finally, because 
indeterminate cells bear similar immunologic markers, but do 
not contain Birbeck granules, the functional significance of this 
structural marker is questionable . 
Because Langerhans and indeterminate cells have been pre-
viously considered to be the only cells that express la-like 
antigens in the epidermis, many studies employing this label 
have been performed to study alterations in Langerhans cell 
numbers. However, a wide variety of infiltrat ing inflammatory 
cells such as B cells, some activated T cells, and mononuclear 
phagocytes (histiocytes, macrophages) express la-like antigens 
as well. Therefore, in diseased skin, in which epidermal infiltra-
tion by mononuclear cells occurs, la positivity cannot be con-
sidered specific for Langerhans cells. 
Reactivity of anti-T6 antibody with intraepidermal Langer-
hans cells has been shown and its specificity documented in 
normal epidermis [7,8). The present study shows that la-like 
antigens as detected by monoclonal anti-II antibody are presen t 
on only 59% (mean) or 52% (mean) as many Langerhans cells 
as defined by T6 positivity in normal epidermis using the PAP 
technique or indir-ect immunofluorescence t echnique, respec-
tively. Thus, anti-Ia antibody reactivity in the systems em-
ployed signifrcantly underestimates the total epidermal popu-
lation of Langerhans cells. Overall, our findings suggest that T6 
reactivity may be a better marker for Langerhans cells not only 
in normal epidermis but also in diseased epidermis in which 
infIltration by mononuclear phagocytes and lymphocytes may 
or may not be present. 
Our study indicates that intraepidermal Langerhans cells and 
indeterminate cells may be Ia(+)/T6(+) or la(-)/T6(+) . Per-
TABLE 1. Expression of Ia (HLA-DR) and T 6 on intraepidennal Langerhans cells 
Subject Location Method Anti-Il 
Number" %" 
1 Extensor forearm PApc 5.5 55 lId 2.6 59 
2 Extensor forearm PAP 4.0 63 
11 1.7 40 
3 Extensor forearm PAP 5.3 58 
4 Posterior shoulder PAP 5.1 59 
5 Posterior shoulder PAP 3.6 60 
Mean (PAP) 4.7 59.0 
(II) 2.2 52.1 
"Number of cells per linear mm of epidermis 
"Number of Ia(+) cells per linear mm/ number of T6(+) cells per linear mm x 100% 
c Immunoperoxidase 
d Indirect immunofluorescence 
Monoclonal antibodies 
Anti-12 Anti T-G 
Number % Number 
1.8 18 10.0 
4.4 
2.9 45 6.4 
4.2 
4.1 46 9.0 
2.8 31 8.8 
2.0 33 6.0 
2.7 34.6 8.0 
4.1 
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haps the l a( +) /T6(+) subset represents an activated state of 
Langerhans or indeterminate cells or a functionally distinct 
subtype. T he la(+) Langerhans cells may be s imilar to the 
la(+) subset of macrophages which are responsible for antigen 
interaction with T cells under la control [20,21)' It is possible 
that in certain disease states or during local immunologic acti-
vation, more T6(+) cells may express la- like (HLA-DR) anti-
gens. Although studies of macrophages in culture showed that 
la-negative macrophages do not acquire la antigen [22], more 
recent evidence implies that the environment may affect the 
expression of la antigens in mouse macrophages. Lastly, the 
quantity of la-like antigens on Langerhans or indeterminate 
cells may not be detectable by our particular methods and 
antibodies. 
In contrast to our obsel·vations, Fithian et al [9] state t hat 
anti-T6 an tibody does not react with non-la-bearing epidermal 
cells in tissue sections. In their study, indirect immunofluores-
cence with anti-II a nd direct immunofluorescence with anti-T6 
were employed in tissue sections. These techniques are not as 
sensit ive as the PAP method. The double-staining technique 
employed in their study does not rule out the possibility of 
nonspecific staining of cells due to binding of fluorescein-labeled 
an ti-T6 a ntibody to rhodamine-conjugated goat-antimouse IgG 
used in the second step of la-like antigen staining. In epidermal 
cell suspension, however, 90% of epidermal-derived T6(+) cells 
were la(+) while 10% were Ia(-) . Virtually all la(+) cells (39/ 
40) were T6-positive. Thus, t he data in epidermal cell suspen-
sions can be interpreted to support our contention that a n 
la(-) / T6(+) Langerhans cell may exist. 
In summary, it appears that monoclonal a ntibodies to l a- like 
antigens label only a portion of Lang'erhans and indeterminate 
cells as defined by reactivity with anti-T6 antibody in normal 
human epidermis and, thus, may significantly underestimate 
their number. As well, techniques employing anti-Ia (HLA-DR) 
antibodies may not accw-ately reflect the number of Langer hans 
cells in diseased epidermis because a variety of exocytotic 
inflammatory cells react with anti-Ia (HLA-DR) antibodies and 
may exhibit cytoplasmic processes similar to the dendrites of 
Langerhans cells. 
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